Keita Mori, MBA, Co-Founder, SanBio Co., Ltd. President, SanBio, Inc. Co-CEO & Chairman
Mr. Mori has been Co-Chief Executive Officer and has served as a member of the Board since SanBio's inception in 2001. Prior to founding SanBio, Mr. Mori was Head of New Product Development from 2000 to 2001 at Xuma, an informatics startup in San Francisco. From 1993 to 1999, Mr. Mori held positions of increasing responsibility in R&D and Manufacturing at Kirin Holdings, Ltd. in Japan. Mr. Mori holds an MBA degree from the University of California, Berkeley and a master's degree in Biochemistry from the University of Tokyo.
Toru Kawanishi, Co-Founder, SanBio Co., Ltd. Executive Chairman, SanBIo, Inc. Co-CEO
Mr. Kawanishi served as SanBio's Chairman of the Board from 2001 to 2005 and has been Co-Chief Executive Officer and a member of the Board since 2005. Prior to founding SanBio, Mr. Kawanishi co-founded CareNet, Inc. (TSE: 2150) and was Executive Vice President from 1996 to 1999. At CareNet, Mr. Kawanishi established eHealthcare in Japan. From 1993 to 1996, Mr. Kawanishi was a management consultant at the Boston Consulting Group. Mr. Kawanishi has a master's degree in Biochemistry from the University of Tokyo.
Noboru Kotani, Outside Director
Mr. Kotani previously worked for the Boston Consulting Group (BCG), a management consulting firm, where he developed business strategies for research and development, manufacturing, new businesses, marketing, sales, organizational structuring, and project management in a variety of businesses, including pharmaceuticals, automobiles, and consumer goods. Mr. Kotani was formerly a BCG senior vice president, a core member of the BCG Worldwide Health Care Practice Group (advisory committee on pharmaceutical businesses). Mr. Kotani established Dream Incubator Inc., a management consulting and a venture capital firm which was listed on the Mothers Section of Tokyo Stock Exchange in its 2nd year, and on the First Section of Tokyo Stock Exchange (TSE, First Section: 4310) in the 6th year after founding. Mr. Kotani has served as an outside director at a number of companies and currently serves as a Director at Santen Pharmaceutical Co., Ltd. [TSE, First Section: 4536], JIN Co., Ltd. [TSE, First Section: 3046], and Combi Corporation). Mr. Kotani graduated from the Faculty of Engineering and completed bachelor’s degree requirements in the Department of Mathematical Engineering and Information Physics, School of Engineering, the University of Tokyo. Mr. Kotani received a Master’s degree in Management Science and Engineering from Stanford University.
Satoshi Fukuda, Outside Auditor (full-time)
Mr. Fukuda worked for the Boston Consulting Group, a management consulting firm, and engaged in strategy building for new businesses, marketing, and organizational structuring in a variety of listed companies, including pharmaceuticals, food companies, and distribution companies, both in Japan and internationally. Mr. Fukuda subsequently founded an IT-related company and engaged in M&A, start-up and management support for a number of venture companies. Mr. Fukuda graduated from the Faculty of Engineering at the University of Tokyo.
Ken Yamazumi, Outside Auditor
Previously, Mr. Yamazumi worked for the Kirin Brewery Company, Ltd., serving as i) the General Manager of the Planning Department in the Pharmaceutical Division, ii) General Manager of the Planning Department, Executive Officer, Vice President, and General Manager of the Licensing Department in the Pharmaceutical Company, and iii) Managing Director, Executive Officer, Vice President, and the head of the Production Technology Research Institute of the Pharmaceutical Company. Mr. Yamazumi was former President and Representative Director of Kirin Pharma Company, Limited. Mr. Yamazumi was former Vice President and Representative Director of Kyowa Hakko Kirin Co., Ltd. (TSE, First Section: 4151). Mr. Yamazumi graduated from the Faculty of Agriculture at the University of Tokyo.
Toshimichi Ueda, Outside director
Mr. Ueda worked for ChuoAoyama Audit Corporation, IPO Department of Daiwa Securities, AnGes MG, Inc. (TSE, Mothers: 4563). He currently serves as a partner in HIBIKI Partners Co., Ltd., an IPO consulting firm. Mr. Ueda was former Executive Officer of AnGes MG, Inc. Mr. Ueda graduated from the Faculty of Business and Commerce, Keio University. Mr. Ueda is a Certified Public Accountant.
Brian D. Frenzel, Board Member of SanBio, Inc.
Mr. Frenzel has served as a member of SanBio Inc.'s Board since 2007. Mr. Frenzel is a life sciences entrepreneur and angel investor. He serves on the boards of directors and the management advisory boards of several private companies. His management experience includes co-founding and serving as CEO or COO and director at Centaur Pharmaceuticals,a neurodegenerative disease pharmaceutical discovery and development company, Vesta Medical, a therapeutic medical device company, Adeza Biomedical, a diagnostic device company, and Genelabs Technologies, a biotechnology company. Prior to entering the startup company arena, Mr. Frenzel was the Director of Corporate Planning at Syntex Corporation, a Principal at Booz, Allen & Hamilton, a consultant at the Boston Consulting Group, and a Lieutenant in the U.S. Navy Nuclear Power Program. Mr. Frenzel holds a BS in physics and an MBA from Stanford University.